Multidrug resistance associated proteins in multidrug resistance.
about
Paclitaxel Through the Ages of Anticancer Therapy: Exploring Its Role in Chemoresistance and Radiation TherapyRecent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs.ARRY-334543 reverses multidrug resistance by antagonizing the activity of ATP-binding cassette subfamily G member 2.Chemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy.Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 yearsMotesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1.Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug ResistanceIn vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1.The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study.ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) are not primary resistance factors for cabazitaxel.Semi-synthetic ocotillol analogues as selective ABCB1-mediated drug resistance reversal agents.ATP-binding cassette transporters in reproduction: a new frontier.Regulation of multidrug resistance by microRNAs in anti-cancer therapyMasitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study.The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatmentPrinciples of biofouling protection in marine sponges: a model for the design of novel biomimetic and bio-inspired coatings in the marine environment?Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance.Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivoNanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer.Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.Tivozanib reverses multidrug resistance mediated by ABCB1 (P-glycoprotein) and ABCG2 (BCRP).PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells.Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10).The therapeutic potential of targeting ABC transporters to combat multi-drug resistance.Gibberellin derivative GA-13315 sensitizes multidrug-resistant cancer cells by antagonizing ABCB1 while agonizes ABCC1.Multidrug resistance protein 4 is a critical protein associated with the antiviral efficacy of nucleos(t)ide analogues.Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers.HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins.PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR.ABCC4 is required for cell proliferation and tumorigenesis in non-small cell lung cancer.Role of ABC transporters in cancer chemotherapy.Activation of the cholinergic anti-inflammatory pathway by GTS-21 attenuates cisplatin-induced acute kidney injury in mice.Quizartinib (AC220) reverses ABCG2-mediated multidrug resistance: In vitro and in vivo studies.Ginger Phytochemicals Inhibit Cell Growth and Modulate Drug Resistance Factors in Docetaxel Resistant Prostate Cancer Cell.ABCC6 plays a significant role in the transport of nilotinib and dasatinib, and contributes to TKI resistance in vitro, in both cell lines and primary patient mononuclear cells.GSK1904529A, a Potent IGF-IR Inhibitor, Reverses MRP1-Mediated Multidrug Resistance.Redox-responsive F127-folate/F127-disulfide bond-d-α-tocopheryl polyethylene glycol 1000 succinate/P123 mixed micelles loaded with paclitaxel for the reversal of multidrug resistance in tumors.A human xenobiotic nuclear receptor contributes to nonresponsiveness of Mycobacterium tuberculosis to the antituberculosis drug rifampicin.
P2860
Q26775004-7F527989-4F5E-4A59-AEFB-0F3346944FF6Q33633267-85F38A1E-9F59-4F25-9A71-0F631B852448Q33861296-20BCDAC5-4B8F-4096-8B0C-7B54B4165458Q33883851-06C0AEB1-ADA4-4D82-9310-5117D15324E2Q34008793-55FF35FD-6D88-4AD6-B28A-C48768363A38Q34046157-8332C96E-7730-4C33-BCB6-8C15A69CAE6BQ34774854-9614822C-8EC1-4D21-A8E2-3AE40B880F9BQ34914312-6B5DE279-58A2-4C21-B7D3-40BBF37D568CQ35238509-58E4FAD2-B10A-418D-8220-C4CDE392767DQ36121125-63EE999E-E535-4427-BF57-7A84F0CEEF2DQ36414444-E31D7F8B-EA9B-4544-BC9B-60BD42E0E3DFQ36585155-1915852A-32ED-4990-8C8F-A2E2AE1CB225Q37587311-9495E9B8-579D-49D1-B764-B6D204DA9F40Q37637660-D57277B5-C721-442D-B30F-A5E6042D02DAQ37693485-464A153C-1127-4B19-9BBC-AF6C897CBD0DQ38092725-5DAB8BC6-FEA3-4CC4-9960-6A61B648FCF5Q38246305-6CED77D3-EB2B-4E89-8812-37F68DD60FAEQ38710502-D5ABCF12-0F51-4A44-81EB-E58E369AA64AQ38813380-C38660EB-4E60-4EC2-BC09-2D5FBD5A8415Q38953085-CB6FFAF1-0D0B-4803-86C4-60CE5E72E5D1Q39015818-44EB83E9-7928-48F6-AABD-DE2C9D9677DDQ39051270-96988AB3-733B-4DA0-BAFB-A435D01E8566Q39152151-85FCDC94-27C5-413C-8B05-5BEE0D3B241FQ39176288-240BCE1C-C537-4431-800F-3F7814F40D00Q39196784-4D0EED07-E629-44AD-A8C7-A86ABA71E641Q39782004-5377168B-1EDC-468F-8239-2AA10B4A3AB3Q40771426-A9CEEB63-432A-433B-BE86-27B406DB9509Q41545913-01E843A5-AA63-447D-B166-8B151F54A128Q41701637-28014D17-BF52-40AE-9C92-D640A9A46587Q41721768-61A56DB7-7234-41A8-A5D3-89101ACF41AEQ41887597-495FB20D-7EE2-49B2-98FC-B8B1421D02C2Q41983373-0248E797-9DD9-4826-AA4F-0648F492FFD4Q42637698-DA429099-4F37-4EEA-AA14-0B8941382737Q46250983-F8FD1353-74E4-45FA-B4A3-5C0C382E4C17Q47139045-5AEABE13-4C08-4C29-A29F-F84A4F295034Q47855461-76B155EE-AC8E-467F-A7E0-8E268F1C74A3Q48133234-25896717-82CE-4C59-8753-08334722EED8Q48156853-3DCE20A7-DEFB-49C8-92BC-42D4477F8A4DQ49549683-3695054C-5708-4F10-A2F0-F94F90A5878CQ49874435-8342889C-D63E-4E06-9BF2-B30A784CB3AE
P2860
Multidrug resistance associated proteins in multidrug resistance.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Multidrug resistance associated proteins in multidrug resistance.
@en
Multidrug resistance associated proteins in multidrug resistance.
@nl
type
label
Multidrug resistance associated proteins in multidrug resistance.
@en
Multidrug resistance associated proteins in multidrug resistance.
@nl
prefLabel
Multidrug resistance associated proteins in multidrug resistance.
@en
Multidrug resistance associated proteins in multidrug resistance.
@nl
P2093
P2860
P921
P356
P1476
Multidrug resistance associated proteins in multidrug resistance
@en
P2093
Kamlesh Sodani
Rishil J Kathawala
Zhe-Sheng Chen
P2860
P356
10.5732/CJC.011.10329
P50
P5008
P577
2011-11-18T00:00:00Z